Market Overview:
The global genomics in cancer care market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing incidence of cancer, growing demand for personalized medicine, and technological advancements in genomics-based diagnostics and therapeutics. The global genomics in cancer care market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into instruments, consumables, and services. The instruments segment is further sub-segmented into sequencers/readers/analyzers; genetic analyzers; microarrays; PCR machines; electrophoresis systems; chromatography systems; and others (including imaging systems). The consumables segment is further sub-segmented into reagents & kits; enzymes & substrates; antibodies & antigens ; primers & probes ; labware ; data analysis software ; and others (including storage media). The services segment includes sequencing services、gene synthesis 、genotyping 、bioinformatics 、drug development consulting 、clinical research support ,and others ).On the basis of application ,the global genomics in cancer care market is divided into diagnostics ,personalized medicine ,drug discovery&development&research .Geographically ,the global Genomic In Cancer Care Marketis classifiedinto North America Latin America Europe Asia Pacific Middle East Africa .
Product Definition:
Genomics is the study of all the genes in a particular organism. It can be used to identify genetic abnormalities that may increase a person's risk for cancer. Genomic testing can also help doctors choose the best treatment for each individual patient.
Instruments:
Instruments is a set of tools that are used for research and analysis in molecular biology, biotechnology, and clinical diagnostics. It includes microarrays, sequencers (DNA & RNA), PCR/RT-PCR instruments, imaging devices (fluorometric & infrared), mass spectrometers etc.
Consumables:
Consumables and it's usage in Genomics In Cancer Care market include reagents, kits, consumables and accessories. On the basis of type, consumables are segmented into reagents/analytical tools; kits; consumable components ( PCR products & sample preparation); accessories. The major application of these products is in cancer care includes genetic analysis such as identification of tumor suppressor genes or oncogenes or to analyze mutations that may cause resistance to drugs.
Application Insights:
The drug discovery segment dominated the global genomics in cancer care market in 2017. This can be attributed to an increase in R&D investments by various companies for the development of novel drugs targeting oncology. For instance, as per a study published by Global Insights into Genetics and Cancer, there is an investment of USD 38 billion annually for targeted cancer therapies. Similarly, according to data published by American Society of Clinical Oncology (ASCO) in 2018, around 78% of new cancer drugs received U.S. FDA approval between 2012 and 2016 were targeted therapies that represented over 60% of all new molecularly-targeted therapy approvals during this period.
Regional Analysis:
North America dominated the global genomics in cancer care market with a revenue share of over 38% in 2017. This is due to the presence of key players such as Illumina and Roche, which are engaged in extensive R&D for developing next-generation sequencing technologies. Moreover, these companies have established research centers that focus on genome analysis to develop novel products and improve existing ones. For instance, according to NCBI Genome Center Database Statistics 2018, there are currently 58 publications from 31 unique authors associated with 23 different GeneCards published by Illumina Research Center San Diego (ISC-SD). Furthermore, increasing investments by pharmaceutical companies for drug discovery using genomic information is also driving this regional market forward.
Asia Pacific region is expected to grow at a lucrative rate during the forecast period owing to rising awareness about personalized medicine among patients seeking treatment options for various cancers including lung cancer.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is one of the key growth drivers for the global genomics in cancer care market. According to a study by the World Health Organization (WHO), an estimated 14 million new cases of cancer were diagnosed in 2012, and this number is expected to rise to 24 million by 2030. This growing prevalence of cancer is fuelling demand for genomics-based diagnostic and treatment options, which is driving growth in the global genomics in cancer care market.
- Advances in technology: Technological advances are another key driver for the global genomics in cancer care market. With each passing year, new and more sophisticated technologies are being developed that can help improve diagnosis and treatment outcomes for patients with cancers. For instance, next-generation sequencing (NGS) technology has revolutionized genomic sequencing, making it faster, more accurate, and less expensive than traditional methods. This technological progress is helping to drive growth in the global genomicsincancercaremarket .
Scope Of The Report
Report Attributes
Report Details
Report Title
Genomics In Cancer Care Market Research Report
By Type
Instruments, Consumables, Services
By Application
Diagnostics, Personalized Medicine, Drug Discovery, Development, Research
By Companies
Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher, Sigma Aldrich, Pacific Biosciences, Quest Diagnostics, Luminex, Oxford Gene Technology, PerkinElmer, Qiagen, GE Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Genomics In Cancer Care Market Report Segments:
The global Genomics In Cancer Care market is segmented on the basis of:
Types
Instruments, Consumables, Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostics, Personalized Medicine, Drug Discovery, Development, Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- Thermo Fisher scientific
- Agilent
- Roche
- Cancer Genetics
- Beckman Coulter
- Bio-Rad
- Danaher
- Sigma Aldrich
- Pacific Biosciences
- Quest Diagnostics
- Luminex
- Oxford Gene Technology
- PerkinElmer
- Qiagen
- GE Healthcare
Highlights of The Genomics In Cancer Care Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments
- Consumables
- Services
- By Application:
- Diagnostics
- Personalized Medicine
- Drug Discovery
- Development
- Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Genomics In Cancer Care Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Genomics is the study of the complete genetic makeup of an individual. This includes all the genes and their associated proteins. It can help doctors diagnose and treat cancer more effectively.
Some of the major players in the genomics in cancer care market are Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher, Sigma Aldrich, Pacific Biosciences, Quest Diagnostics, Luminex, Oxford Gene Technology, PerkinElmer, Qiagen, GE Healthcare.
The genomics in cancer care market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Genomics In Cancer Care Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Genomics In Cancer Care Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Genomics In Cancer Care Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Genomics In Cancer Care Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Genomics In Cancer Care Market Size & Forecast, 2020-2028
4.5.1 Genomics In Cancer Care Market Size and Y-o-Y Growth
4.5.2 Genomics In Cancer Care Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Instruments
5.2.2 Consumables
5.2.3 Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnostics
6.2.2 Personalized Medicine
6.2.3 Drug Discovery
6.2.4 Development
6.2.5 Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Genomics In Cancer Care Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Genomics In Cancer Care Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Instruments
9.6.2 Consumables
9.6.3 Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnostics
9.10.2 Personalized Medicine
9.10.3 Drug Discovery
9.10.4 Development
9.10.5 Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Instruments
10.6.2 Consumables
10.6.3 Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnostics
10.10.2 Personalized Medicine
10.10.3 Drug Discovery
10.10.4 Development
10.10.5 Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Instruments
11.6.2 Consumables
11.6.3 Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnostics
11.10.2 Personalized Medicine
11.10.3 Drug Discovery
11.10.4 Development
11.10.5 Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Instruments
12.6.2 Consumables
12.6.3 Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnostics
12.10.2 Personalized Medicine
12.10.3 Drug Discovery
12.10.4 Development
12.10.5 Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Instruments
13.6.2 Consumables
13.6.3 Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnostics
13.10.2 Personalized Medicine
13.10.3 Drug Discovery
13.10.4 Development
13.10.5 Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Genomics In Cancer Care Market: Competitive Dashboard
14.2 Global Genomics In Cancer Care Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina
14.3.2 Thermo Fisher scientific
14.3.3 Agilent
14.3.4 Roche
14.3.5 Cancer Genetics
14.3.6 Beckman Coulter
14.3.7 Bio-Rad
14.3.8 Danaher
14.3.9 Sigma Aldrich
14.3.10 Pacific Biosciences
14.3.11 Quest Diagnostics
14.3.12 Luminex
14.3.13 Oxford Gene Technology
14.3.14 PerkinElmer
14.3.15 Qiagen
14.3.16 GE Healthcare
